- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity ; volume:9 ; number:1 ; day:18 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
npj vaccines ; 9, Heft 1 (18.11.2024), 1-10, 12.2024
- Urheber
-
D’Souza, Mathieu
Keeshan, Alexa
Gravel, Christopher A.
Langlois, Marc-André
Cooper, Curtis L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-024-01022-8
- URN
-
urn:nbn:de:101:1-2502042107011.740574799815
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:27 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- D’Souza, Mathieu
- Keeshan, Alexa
- Gravel, Christopher A.
- Langlois, Marc-André
- Cooper, Curtis L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine
Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Sex differences in vaccine-induced humoral immunity
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
Immunogenicity of infectious pathogens and vaccine antigens
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS‐CoV‐2 Subunit Vaccine
A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine
Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Sex differences in vaccine-induced humoral immunity
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
Immunogenicity of infectious pathogens and vaccine antigens
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS‐CoV‐2 Subunit Vaccine
A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine
Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Sex differences in vaccine-induced humoral immunity
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
Immunogenicity of infectious pathogens and vaccine antigens
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS‐CoV‐2 Subunit Vaccine
A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2